PTHS AMEX
Pelthos Therapeutics Inc.
1W: +1.2%
1M: -5.5%
3M: +19.6%
YTD: -6.3%
1Y: +25.4%
$27.77
+0.18 (+0.65%)
After Hours: $28.46 (+0.70, +2.50%)
Weekly Expected Move ±11.8%
$20
$23
$26
$29
$32
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$1.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$18.0M
52W Range16.5-37.5
Volume103,832
Avg Volume30,487
Beta3.13
Dividend—
Analyst Ratings
Company Info
CEOScott Plesha
Employees92
SectorHealthcare
IndustryBiotechnology
IPO Date2024-02-16
Websitepelthos.com
4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703
Durham, NC 27703
US
Durham, NC 27703
US
877 265 8266
About Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
Latest News
Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Pelthos Therapeutics names John M. Gay as CFO
Pelthos Therapeutics Announces CFO Transition
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Friedberg Ezra M | S-Sale | 534 | $26.03 | 2026-07-02 |
| Friedberg Ezra M | S-Sale | 24 | $27.33 | 2026-07-02 |
| Pauls Matthew | S-Sale | 692 | $26.00 | 2026-07-02 |
| Pauls Matthew | S-Sale | 94 | $27.36 | 2026-07-02 |
| Greenleaf Peter | S-Sale | 712 | $26.00 | 2026-07-02 |